Susquehanna International Group
PROK icon

Susquehanna International Group’s ProKidney PROK Stock Holding History

Susquehanna International Group’s Portfolio PROK Stock Details PROK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-128,500
Closed -$288K – 13907
2025
Q4 		$288K Sell
128,500
-52,100
-29% -$137K ﹤0.01% 10051
2025
Q3 		$437K Buy
+180,600
New +$481K ﹤0.01% 9266

Other funds holding PROK

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
AGP
Artia Global Partners Miami, Florida $499M AUM 186.05% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Susquehanna International Group's PROK Position: Q1 2026 in Review

Susquehanna International Group reduced its ProKidney (PROK) stake by 49% in Q1 2026, selling an estimated $412K and leaving 204,488 shares worth $366K. The position accounts for ﹤0.01% of the portfolio, ranked #10424.

Susquehanna International Group first reported a position in PROK in Q2 2023 and has held it in 9 quarters since. The position peaked at $893K in Q4 2025. 71 funds tracked by Wall St. Rank hold PROK as of Q1 2026.

  • Susquehanna International Group held 204,488 shares of ProKidney worth $366K as of Q1 2026.
  • Susquehanna International Group sold 194,392 ProKidney shares in Q1 2026, an estimated $412K.
  • ProKidney made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #10424 holding.
  • Susquehanna International Group first reported a position in ProKidney in Q2 2023 and has held it in 9 quarters since.
  • Susquehanna International Group's ProKidney position peaked at $893K in Q4 2025.
  • 71 funds tracked by Wall St. Rank held ProKidney as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.